You are here


12 Sep 2013
Researchers of the University of Oxford have identified a genetic signature that is significantly associated with survival of patients with blood disorders known as myelodysplastic syndromes (MDS). MDS is characterized by a loss of normal blood cell development and accumulation of defective blood cells in the bone marrow leading to development of acute myeloid leukemia (AML) in up to 40% of cases ...
21 Aug 2013
Welcome to the 1st newsletter of SyStemAge. The aim of this newsletter is to share project news and events within the consortium and the general public.
3 Jun 2013
SyStemAge is happy to present the new website!
30 May 2013
Headed by EMBL in Germany, the consortium “SyStemAge” seeks to identify the molecular mechanisms behind aging and the consequences of this process, and also to propose biomarkers to combat age-related diseases. The consortium involves clinical researchers, biologists specialized in two types of blood cancer, systems biologists, and biotech managers. Read the full press release on IRB Barcelona ...